Advertisement

Topics

New partnership set to provide AI for UK drug discovery market

05:51 EDT 13 May 2019 | EPM Magazine

UK drug discovery researchers will soon be able to use artificial intelligence (AI) to support their projects thanks to a partnership between Medicines Discovery Catapult and the online platform Chief.AI.

Original Article: New partnership set to provide AI for UK drug discovery market

NEXT ARTICLE

More From BioPortfolio on "New partnership set to provide AI for UK drug discovery market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...